SNDL Closes Parallel Acquisition, Gains 56 U.S. Cannabis Stores and $150M Revenue Platform
SNDL is trading near its 52-week low of $1.24 (2.0% above the low) on light trading volume (0.3× avg).
Summary
SNDL completed its acquisition of Parallel's assets, adding 56 retail locations and 3 cultivation facilities across Florida, Texas, and Massachusetts. The deal gives SNDL indirect majority economic exposure—66.7% of equity and 69.4% of debt in the acquiring entity—with plans to convert to direct consolidated holdings, potentially making it one of the first Nasdaq-listed companies with direct U.S. medical cannabis operations. The acquired assets generate approximately US$150 million in annualized revenue and are profitable, providing an immediate scale-up in the U.S. market. This follows the initial announcement on April 29, 2026, and represents the culmination of a multi-year restructuring of a legacy credit investment. The move significantly expands SNDL's footprint beyond Canada, leveraging its retail expertise in a consolidating U.S. cannabis market. With the stock trading near its 52-week low, this transformative acquisition could shift market perception of SNDL's growth trajectory.
At the time of this announcement, SNDL was trading at $1.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $329.3M. The 52-week trading range was $1.24 to $2.89. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.